Conversation

Replying to
There's been a lot of discussion on responsibility of pharma companies like Pfizer/Moderna for access. What is the role of these companies in ensuring pricing and availability esp in low and middle income contexts?
1
404
Replying to
When we have adequate supply then tiered pricing is used where the rich countries pay a lot more than middle income and low income pay the least which is funded by . When supply is limited rich countries have to not outbid the others so governments are key to this. #
1
203
Replying to and
A few countries like Australia moved fast to diagnose cases at scale and isolate people who were infected. They were able to limit deaths dramatically. Once the numbers get large in a country it is too late. So the first few months made a lot of difference.
1
310
Replying to and
I'm optimistic about the '100 day challenge'- the idea of sequencing a new genome to developing diagnostics, therapeutics and effective vaccines- and getting them out to people. But requires leadership, planning & foresight. Now is the window to prepare.#
1
386
Replying to and
Trusted authorities like and need more resources to see the pandemic early (surveillance) and to communicate better. Social media got behind on trying to get factual information out - there will be a lot of debate about how to do better on that...
1
209
From 2000 to the start of the pandemic we made strong progress on health and other goals. The pandemic is a huge setback - including rich countries not focusing on the needs of developing countries as much. I hope we can reverse that.
1
181
Show replies